Português English
Our team


 

Dr. Ricardo Perdigão Henriques
CEO


Ricardo Perdigão Henriques is the CEO of Hovione Capital. He leads the identification of new investment opportunities and the management of Hovione Capital’s portfolio companies. He is an Harvard and MIT-educated scientist with a B.Sc. in Biochemistry and a Ph.D. in Molecular Oncology, with publications in high-ranking journals such as the Journal of Clinical Investigation, Oncogene (Nature Publishing Group), and Biotechnology Progress.
Ricardo has over 15 years of experience in Life Sciences, from Biomedical Research, to Pharmaceutical Industry and Venture Capital. Prior to joining Hovione Capital, he was an Investment Manager at Portugal Ventures and an International Business Development and Licensing Analyst at BIAL.



      




Peter Villax
Chairman

Peter Villax is Hovione Capital’s Chairman. He joined Hovione in 1982 as a computer programmer and led Hovione’s computerization, then switched to pharmaceutical development in 1990 and soon became interested in in pulmonary delivery. His disposable dry-powder inhaler TwinCaps, licensed to Daiichi Sankyo for the delivery of Influenza drug Inavir®, continues to be the only commercial device of its kind in the world, and has helped Daiichi Sankyo become the market leader in influenza products in Japan. He acquired significant experience as an inventor of devices, as a patentholder and as licensor of technology patents. In 2013 together with Miguel Calado, he was involved in a 7-figure royalty monetization deal with a US-based financial company, under which Hovione sold the future income streams earned under a license  agreement. 

Peter Villax is also active in civic duties, as president of the Family Business Association in Portugal, a member of three University faculty boards (Pharmacy in U. Coimbra, Medicine in U.Lisbon and the Institute of Chemical and Biological Technology in U.Nova) as well as of other organizations. He is a lecturer and a frequent speaker at scientific, academic and business conferences and an ocasional participant in TV programmes.






      





return